Loading…
By blocking hexokinase-2 phosphorylation, limonin suppresses tumor glycolysis and induces cell apoptosis in hepatocellular carcinoma
The purpose of present study was to investigate the effect of limonin on tumor glycolysis and the underlying mechanisms in hepatocellular carcinoma (HCC). Cell proliferation and colony formation assays were performed to evaluate the potency of limonin against HCC cells in vitro. The glucose consumpt...
Saved in:
Published in: | OncoTargets and therapy 2018-01, Vol.11, p.3793-3803 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c507t-5fab034221f1bca3a26fb77b6ecf0538bdad5a1d53e8aae6e881bcbb163625bf3 |
---|---|
cites | |
container_end_page | 3803 |
container_issue | |
container_start_page | 3793 |
container_title | OncoTargets and therapy |
container_volume | 11 |
creator | Yao, Junliang Liu, Jingtian Zhao, Wensheng |
description | The purpose of present study was to investigate the effect of limonin on tumor glycolysis and the underlying mechanisms in hepatocellular carcinoma (HCC).
Cell proliferation and colony formation assays were performed to evaluate the potency of limonin against HCC cells in vitro. The glucose consumption and lactate production after limonin treatment was determined. The effect of limonin on hexokinase-2 (HK-2) activity was assessed and the mitochondrial location of HK-2 was studied by immunoprecipitation. Cell apoptosis and protein expression were detected by flow cytometry and western blotting respectively. Protein overexpression by plasmid transfection was adopted to investigate the molecular mechanisms.
HCC proliferation and colony formation were inhibited by limonin in vitro. With the suppression of HK-2 activity, the glycolytic level in HCC cells was substantially reduced, which was evidenced by the decrease of glucose consumption and lactate production. The phosphorylation of HK-2 was substantially inhibited by limonin, which resulted in the disassociation of HK-2 from mitochondria. Due to the reduction of HK-2 in mitochondria, increasing Bax were shifted to the mitochondria and gave rise to the release of cytochrome C, which induced HCC cells to subject to mitochondria-mediated apoptosis. Mechanism investigations revealed that the decrease of HK-2 phosphorylation was mainly due to the inhibition of Akt activity. In Akt exogenously overexpressed HCC cells, limonin-mediated cell proliferation inhibition, glycolysis suppression and apoptosis induction were significantly impaired.
Limonin inhibited the tumor glycolysis in hepatocellular carcinoma by suppressing HK-2 activity, and the suppression of HK-2 was closely related to the decrease of Akt activity. |
doi_str_mv | 10.2147/OTT.S165220 |
format | article |
fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6037266</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A583694817</galeid><sourcerecordid>A583694817</sourcerecordid><originalsourceid>FETCH-LOGICAL-c507t-5fab034221f1bca3a26fb77b6ecf0538bdad5a1d53e8aae6e881bcbb163625bf3</originalsourceid><addsrcrecordid>eNptkl2L1TAQhoso7rp65b0EBBG0x3w0afdGWBe_YGEvPF6HSZqeZk2TmrRi7_3hpuxxPUckhAwzz7xhkrconhK8oaSq31xvt5svRHBK8b3ilJC6KcU5w_cP4pPiUUo3GAvR0OphccIwJowJfFr8ercg5YL-Zv0O9eZnyAEkU1I09iHlHRcHkw3-NXJ2CN56lOZxjCYlk9A0DyGinVt0cEuyCYFvkfXtrHNRG-cQjGGcwlrKnb0ZYQprfnYQkYaorQ8DPC4edOCSebI_z4qvH95vLz-VV9cfP19eXJWa43oqeQcKs4pS0hGlgQEVnaprJYzuMGeNaqHlQFrOTANghGmazClFBBOUq46dFW9vdcdZDabVxk8RnByjHSAuMoCVxxVve7kLP6TArKZCZIGXe4EYvs8mTXKwaZ0HvAlzkhTXhIuKNyv6_B_0JszR5_EkpRXlmIsa_6V24Iy0vgv5Xr2KygveMHFeNaTO1OY_VF6tGawO3nQ2548aXhw09Abc1Kfg5vUj0zH46hbUMaQUTXf3GATL1V0yu0vu3ZXpZ4fvd8f-sRP7DRrPzTI</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2242505670</pqid></control><display><type>article</type><title>By blocking hexokinase-2 phosphorylation, limonin suppresses tumor glycolysis and induces cell apoptosis in hepatocellular carcinoma</title><source>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</source><source>Taylor & Francis_OA刊</source><source>PubMed Central</source><creator>Yao, Junliang ; Liu, Jingtian ; Zhao, Wensheng</creator><creatorcontrib>Yao, Junliang ; Liu, Jingtian ; Zhao, Wensheng</creatorcontrib><description>The purpose of present study was to investigate the effect of limonin on tumor glycolysis and the underlying mechanisms in hepatocellular carcinoma (HCC).
Cell proliferation and colony formation assays were performed to evaluate the potency of limonin against HCC cells in vitro. The glucose consumption and lactate production after limonin treatment was determined. The effect of limonin on hexokinase-2 (HK-2) activity was assessed and the mitochondrial location of HK-2 was studied by immunoprecipitation. Cell apoptosis and protein expression were detected by flow cytometry and western blotting respectively. Protein overexpression by plasmid transfection was adopted to investigate the molecular mechanisms.
HCC proliferation and colony formation were inhibited by limonin in vitro. With the suppression of HK-2 activity, the glycolytic level in HCC cells was substantially reduced, which was evidenced by the decrease of glucose consumption and lactate production. The phosphorylation of HK-2 was substantially inhibited by limonin, which resulted in the disassociation of HK-2 from mitochondria. Due to the reduction of HK-2 in mitochondria, increasing Bax were shifted to the mitochondria and gave rise to the release of cytochrome C, which induced HCC cells to subject to mitochondria-mediated apoptosis. Mechanism investigations revealed that the decrease of HK-2 phosphorylation was mainly due to the inhibition of Akt activity. In Akt exogenously overexpressed HCC cells, limonin-mediated cell proliferation inhibition, glycolysis suppression and apoptosis induction were significantly impaired.
Limonin inhibited the tumor glycolysis in hepatocellular carcinoma by suppressing HK-2 activity, and the suppression of HK-2 was closely related to the decrease of Akt activity.</description><identifier>ISSN: 1178-6930</identifier><identifier>EISSN: 1178-6930</identifier><identifier>DOI: 10.2147/OTT.S165220</identifier><identifier>PMID: 30013360</identifier><language>eng</language><publisher>New Zealand: Dove Medical Press Limited</publisher><subject>Apoptosis ; Brain cancer ; Breast cancer ; Cancer ; Carcinoma ; Cardiomyocytes ; Citrus ; Cytochrome c ; Glucose ; Glucose metabolism ; Hepatocellular carcinoma ; Infection ; Kinases ; Liver cancer ; Medical prognosis ; Metabolism ; Mitochondria ; Original Research ; Phosphorylation ; Proteins ; Tumors</subject><ispartof>OncoTargets and therapy, 2018-01, Vol.11, p.3793-3803</ispartof><rights>COPYRIGHT 2018 Dove Medical Press Limited</rights><rights>2018. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2018 Yao et al. This work is published and licensed by Dove Medical Press Limited 2018</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c507t-5fab034221f1bca3a26fb77b6ecf0538bdad5a1d53e8aae6e881bcbb163625bf3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2242505670/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2242505670?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30013360$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yao, Junliang</creatorcontrib><creatorcontrib>Liu, Jingtian</creatorcontrib><creatorcontrib>Zhao, Wensheng</creatorcontrib><title>By blocking hexokinase-2 phosphorylation, limonin suppresses tumor glycolysis and induces cell apoptosis in hepatocellular carcinoma</title><title>OncoTargets and therapy</title><addtitle>Onco Targets Ther</addtitle><description>The purpose of present study was to investigate the effect of limonin on tumor glycolysis and the underlying mechanisms in hepatocellular carcinoma (HCC).
Cell proliferation and colony formation assays were performed to evaluate the potency of limonin against HCC cells in vitro. The glucose consumption and lactate production after limonin treatment was determined. The effect of limonin on hexokinase-2 (HK-2) activity was assessed and the mitochondrial location of HK-2 was studied by immunoprecipitation. Cell apoptosis and protein expression were detected by flow cytometry and western blotting respectively. Protein overexpression by plasmid transfection was adopted to investigate the molecular mechanisms.
HCC proliferation and colony formation were inhibited by limonin in vitro. With the suppression of HK-2 activity, the glycolytic level in HCC cells was substantially reduced, which was evidenced by the decrease of glucose consumption and lactate production. The phosphorylation of HK-2 was substantially inhibited by limonin, which resulted in the disassociation of HK-2 from mitochondria. Due to the reduction of HK-2 in mitochondria, increasing Bax were shifted to the mitochondria and gave rise to the release of cytochrome C, which induced HCC cells to subject to mitochondria-mediated apoptosis. Mechanism investigations revealed that the decrease of HK-2 phosphorylation was mainly due to the inhibition of Akt activity. In Akt exogenously overexpressed HCC cells, limonin-mediated cell proliferation inhibition, glycolysis suppression and apoptosis induction were significantly impaired.
Limonin inhibited the tumor glycolysis in hepatocellular carcinoma by suppressing HK-2 activity, and the suppression of HK-2 was closely related to the decrease of Akt activity.</description><subject>Apoptosis</subject><subject>Brain cancer</subject><subject>Breast cancer</subject><subject>Cancer</subject><subject>Carcinoma</subject><subject>Cardiomyocytes</subject><subject>Citrus</subject><subject>Cytochrome c</subject><subject>Glucose</subject><subject>Glucose metabolism</subject><subject>Hepatocellular carcinoma</subject><subject>Infection</subject><subject>Kinases</subject><subject>Liver cancer</subject><subject>Medical prognosis</subject><subject>Metabolism</subject><subject>Mitochondria</subject><subject>Original Research</subject><subject>Phosphorylation</subject><subject>Proteins</subject><subject>Tumors</subject><issn>1178-6930</issn><issn>1178-6930</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNptkl2L1TAQhoso7rp65b0EBBG0x3w0afdGWBe_YGEvPF6HSZqeZk2TmrRi7_3hpuxxPUckhAwzz7xhkrconhK8oaSq31xvt5svRHBK8b3ilJC6KcU5w_cP4pPiUUo3GAvR0OphccIwJowJfFr8ercg5YL-Zv0O9eZnyAEkU1I09iHlHRcHkw3-NXJ2CN56lOZxjCYlk9A0DyGinVt0cEuyCYFvkfXtrHNRG-cQjGGcwlrKnb0ZYQprfnYQkYaorQ8DPC4edOCSebI_z4qvH95vLz-VV9cfP19eXJWa43oqeQcKs4pS0hGlgQEVnaprJYzuMGeNaqHlQFrOTANghGmazClFBBOUq46dFW9vdcdZDabVxk8RnByjHSAuMoCVxxVve7kLP6TArKZCZIGXe4EYvs8mTXKwaZ0HvAlzkhTXhIuKNyv6_B_0JszR5_EkpRXlmIsa_6V24Iy0vgv5Xr2KygveMHFeNaTO1OY_VF6tGawO3nQ2548aXhw09Abc1Kfg5vUj0zH46hbUMaQUTXf3GATL1V0yu0vu3ZXpZ4fvd8f-sRP7DRrPzTI</recordid><startdate>20180101</startdate><enddate>20180101</enddate><creator>Yao, Junliang</creator><creator>Liu, Jingtian</creator><creator>Zhao, Wensheng</creator><general>Dove Medical Press Limited</general><general>Taylor & Francis Ltd</general><general>Dove Medical Press</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M2O</scope><scope>M7P</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20180101</creationdate><title>By blocking hexokinase-2 phosphorylation, limonin suppresses tumor glycolysis and induces cell apoptosis in hepatocellular carcinoma</title><author>Yao, Junliang ; Liu, Jingtian ; Zhao, Wensheng</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c507t-5fab034221f1bca3a26fb77b6ecf0538bdad5a1d53e8aae6e881bcbb163625bf3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Apoptosis</topic><topic>Brain cancer</topic><topic>Breast cancer</topic><topic>Cancer</topic><topic>Carcinoma</topic><topic>Cardiomyocytes</topic><topic>Citrus</topic><topic>Cytochrome c</topic><topic>Glucose</topic><topic>Glucose metabolism</topic><topic>Hepatocellular carcinoma</topic><topic>Infection</topic><topic>Kinases</topic><topic>Liver cancer</topic><topic>Medical prognosis</topic><topic>Metabolism</topic><topic>Mitochondria</topic><topic>Original Research</topic><topic>Phosphorylation</topic><topic>Proteins</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yao, Junliang</creatorcontrib><creatorcontrib>Liu, Jingtian</creatorcontrib><creatorcontrib>Zhao, Wensheng</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>ProQuest research library</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>OncoTargets and therapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yao, Junliang</au><au>Liu, Jingtian</au><au>Zhao, Wensheng</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>By blocking hexokinase-2 phosphorylation, limonin suppresses tumor glycolysis and induces cell apoptosis in hepatocellular carcinoma</atitle><jtitle>OncoTargets and therapy</jtitle><addtitle>Onco Targets Ther</addtitle><date>2018-01-01</date><risdate>2018</risdate><volume>11</volume><spage>3793</spage><epage>3803</epage><pages>3793-3803</pages><issn>1178-6930</issn><eissn>1178-6930</eissn><abstract>The purpose of present study was to investigate the effect of limonin on tumor glycolysis and the underlying mechanisms in hepatocellular carcinoma (HCC).
Cell proliferation and colony formation assays were performed to evaluate the potency of limonin against HCC cells in vitro. The glucose consumption and lactate production after limonin treatment was determined. The effect of limonin on hexokinase-2 (HK-2) activity was assessed and the mitochondrial location of HK-2 was studied by immunoprecipitation. Cell apoptosis and protein expression were detected by flow cytometry and western blotting respectively. Protein overexpression by plasmid transfection was adopted to investigate the molecular mechanisms.
HCC proliferation and colony formation were inhibited by limonin in vitro. With the suppression of HK-2 activity, the glycolytic level in HCC cells was substantially reduced, which was evidenced by the decrease of glucose consumption and lactate production. The phosphorylation of HK-2 was substantially inhibited by limonin, which resulted in the disassociation of HK-2 from mitochondria. Due to the reduction of HK-2 in mitochondria, increasing Bax were shifted to the mitochondria and gave rise to the release of cytochrome C, which induced HCC cells to subject to mitochondria-mediated apoptosis. Mechanism investigations revealed that the decrease of HK-2 phosphorylation was mainly due to the inhibition of Akt activity. In Akt exogenously overexpressed HCC cells, limonin-mediated cell proliferation inhibition, glycolysis suppression and apoptosis induction were significantly impaired.
Limonin inhibited the tumor glycolysis in hepatocellular carcinoma by suppressing HK-2 activity, and the suppression of HK-2 was closely related to the decrease of Akt activity.</abstract><cop>New Zealand</cop><pub>Dove Medical Press Limited</pub><pmid>30013360</pmid><doi>10.2147/OTT.S165220</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1178-6930 |
ispartof | OncoTargets and therapy, 2018-01, Vol.11, p.3793-3803 |
issn | 1178-6930 1178-6930 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6037266 |
source | Publicly Available Content Database (Proquest) (PQ_SDU_P3); Taylor & Francis_OA刊; PubMed Central |
subjects | Apoptosis Brain cancer Breast cancer Cancer Carcinoma Cardiomyocytes Citrus Cytochrome c Glucose Glucose metabolism Hepatocellular carcinoma Infection Kinases Liver cancer Medical prognosis Metabolism Mitochondria Original Research Phosphorylation Proteins Tumors |
title | By blocking hexokinase-2 phosphorylation, limonin suppresses tumor glycolysis and induces cell apoptosis in hepatocellular carcinoma |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T14%3A14%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=By%20blocking%20hexokinase-2%20phosphorylation,%20limonin%20suppresses%20tumor%20glycolysis%20and%20induces%20cell%20apoptosis%20in%20hepatocellular%20carcinoma&rft.jtitle=OncoTargets%20and%20therapy&rft.au=Yao,%20Junliang&rft.date=2018-01-01&rft.volume=11&rft.spage=3793&rft.epage=3803&rft.pages=3793-3803&rft.issn=1178-6930&rft.eissn=1178-6930&rft_id=info:doi/10.2147/OTT.S165220&rft_dat=%3Cgale_pubme%3EA583694817%3C/gale_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c507t-5fab034221f1bca3a26fb77b6ecf0538bdad5a1d53e8aae6e881bcbb163625bf3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2242505670&rft_id=info:pmid/30013360&rft_galeid=A583694817&rfr_iscdi=true |